HSA | FSA CARDS ARE NOW ACCEPTED

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Human longevity research has identified hundreds of genetic variants associated with lifespan, healthspan, and biological aging rate. Of all of them, one stands apart in the consistency and scale of its replication across independent populations: FOXO3 — the forkhead box O3 transcription factor gene, whose variants have been associated with exceptional longevity in study populations spanning Japan, Germany, the United States, Italy, Denmark, and China.

But FOXO3 does not work alone. The biology of cellular aging is a network — a set of interconnected pathways governing how cells respond to stress, repair DNA damage, regulate inflammation, maintain telomere integrity, and decide whether to divide, enter senescence, or undergo programmed death. Your inherited genetic profile across this entire network shapes how your cells age, how resilient your biology is to the accumulated damage of decades, and — increasingly — what the research literature suggests about which biological pathways may be most relevant to support as part of a longevity-focused protocol.

The PlexusDx Precision Peptide Genetic Test analyzes 17 genetic insights in the Longevity & Aging pathway — one of 14 peptide-related biological pathways in the full panel. Here is what your cellular aging genetics actually measure, and why understanding your inherited longevity biology is the foundational step before any aging-focused biological protocol begins.

The Biology of Cellular Aging: Five Systems Your Genetics Govern

Biological aging is not a single event — it is the cumulative outcome of multiple cellular processes that operate in parallel across every tissue in the body. Understanding which of these systems show the most genetic variability, and how your inherited profile shapes each one, is the framework for interpreting your Longevity & Aging pathway results.

1. Telomere Maintenance and TERT

Telomeres are the protective caps at the ends of chromosomes — repetitive DNA sequences that shorten by a measurable amount each time a cell divides. When telomeres reach a critically short length, the cell enters replicative senescence or triggers apoptosis. Telomere length is therefore a widely studied marker of cellular biological age, with shorter telomeres associated in epidemiological studies with earlier onset of age-related biological decline across multiple organ systems.

Telomerase reverse transcriptase (TERT) is the enzymatic engine of telomere maintenance — the protein that adds telomeric repeats to chromosome ends in cells with active telomerase, partially offsetting the shortening that accompanies each cell division. Genetic variants in the TERT gene and its regulatory regions influence telomerase expression levels, telomere elongation efficiency, and the rate at which telomere attrition accumulates across the lifespan. TERT promoter variants have been studied extensively in both cancer biology and aging research — occupying the interesting position of being relevant to both longevity (more telomere maintenance) and oncology (unchecked telomere maintenance in malignant cells). Context and genotype together determine which direction the biological tendency runs.

Understanding your TERT genotype does not tell you your telomere length — that requires a separate measurement. What it tells you is something more durable: how your inherited telomerase expression architecture differs from the population baseline, and what that means for the biological systems you and your healthcare provider are designing a longevity protocol around.

2. FOXO3 and the Stress Resistance Signaling Network

FOXO3 is a transcription factor that regulates the expression of genes involved in cell cycle arrest, DNA damage repair, oxidative stress resistance, and apoptosis. It sits at a critical junction in the insulin/IGF-1 signaling (IIS) pathway — the same pathway that governs aging rate in model organisms from C. elegans to mice — functioning as a downstream regulator that is activated when insulin/IGF-1 signaling is reduced and cells need to shift into stress-resistance and repair mode.

The FOXO3 rs2802292 variant — a G/T polymorphism in an intronic region — is the most consistently replicated genetic association with human longevity in the published literature. The G allele has been associated with exceptional longevity (reaching age 95+) in multiple independent cohorts across different ancestral populations, in both men and women, with effect sizes that remain significant after controlling for other longevity-associated variables. The proposed mechanism involves altered FOXO3 expression in response to cellular stress — with the longevity-associated allele potentially producing a more robust stress-activated FOXO3 response, which then upregulates downstream genes involved in oxidative stress detoxification, DNA repair fidelity, and cellular quality control.

FOXO3's position in the IIS pathway also connects it directly to the broader peptide biology research landscape. The IIS/FOXO signaling axis is one of the most intensively studied targets in aging biology, and it intersects with the growth hormone, insulin, and IGF-1 pathways that are themselves central to the peptide research literature. Understanding your FOXO3 genotype provides direct insight into one of the most biologically upstream regulators of your inherited stress resistance and cellular longevity architecture.

3. The mTOR Pathway and Cellular Resource Allocation

The mechanistic target of rapamycin (mTOR) is a master regulator of cellular metabolism — a protein kinase that acts as a nutrient-sensing hub, integrating signals from amino acid availability, energy status, and growth factors to determine whether cells should prioritize anabolic growth and proliferation or shift resources toward autophagy, cellular maintenance, and stress resistance.

In the context of aging biology, mTOR activity is often framed as a trade-off: high mTOR signaling drives growth and anabolism during periods of nutrient abundance, but chronically elevated mTOR activity suppresses autophagy — the cellular recycling process that clears damaged proteins and dysfunctional organelles. Reduced autophagy efficiency is associated with the accumulation of cellular debris that characterizes many aspects of biological aging across tissues.

Genetic variants in MTOR and its upstream regulators — including RPTOR and components of the PI3K/AKT pathway — influence baseline mTOR activity levels and the sensitivity of the mTOR pathway to nutritional and metabolic signals. Individuals with inherited differences in mTOR signaling set points may experience different balances between anabolic efficiency and autophagic cellular maintenance across the lifespan, with potential implications for biological aging trajectory, metabolic resilience, and cellular quality control capacity.

4. SIRT1 and the NAD⁺-Dependent Longevity Pathway

Sirtuin 1 (SIRT1) is an NAD⁺-dependent deacetylase — an enzyme that removes acetyl groups from target proteins in an NAD⁺-consuming reaction, linking its activity directly to cellular energy status and metabolic state. SIRT1 regulates an extensive range of longevity-relevant biological processes: DNA damage response and repair, mitochondrial biogenesis (via PGC-1α activation), inflammation suppression, and metabolic adaptation to caloric restriction.

The connection between SIRT1, NAD⁺ availability, and aging has generated significant research interest because NAD⁺ levels decline measurably with age across multiple tissues — creating a scenario where age-related NAD⁺ depletion progressively limits SIRT1 activity precisely when its longevity-relevant functions are most needed. Genetic variants in SIRT1 influence baseline deacetylase activity, the efficiency of SIRT1's interaction with downstream targets like PGC-1α and p53, and the sensitivity of the SIRT1 pathway to NAD⁺ fluctuations.

Understanding your SIRT1 genotype provides context for interpreting your inherited NAD⁺/SIRT1 axis biology — including how your cells' longevity signaling capacity may respond to nutritional, metabolic, and lifestyle inputs that influence NAD⁺ availability and SIRT1 pathway activation.

5. KLOTHO: The Aging Suppressor Gene

KLOTHO is one of the most compelling genes in human longevity research — a transmembrane protein that functions both as a co-receptor for fibroblast growth factor 23 (FGF23) and as a shed circulating factor with pleiotropic anti-aging effects across multiple organ systems. The name derives directly from its discovery context: mice lacking KLOTHO develop a syndrome of accelerated aging, while mice overexpressing KLOTHO live significantly longer than wild-type controls.

In humans, the KL-VS haplotype — particularly the rs9536314 and rs9527025 variants — has been associated with differences in circulating KLOTHO levels and with longevity outcomes in epidemiological studies. Heterozygous carriers of KL-VS appear in some research populations to show modest longevity advantages, while homozygous carriers may show attenuated Klotho signaling — an interesting dose-dependent pattern consistent with evolutionary trade-off frameworks in aging biology.

KLOTHO's biological functions span phosphate and calcium metabolism, oxidative stress suppression, insulin and IGF-1 signaling modulation, and cognitive aging — making it a genuinely multi-system longevity gene whose effects are not reducible to a single organ or pathway. Understanding your KLOTHO genotype provides insight into one of the most upstream biological regulators of aging biology that human genetics has identified.

Why Longevity Pathway Genetics Matter Before Any Anti-Aging Protocol

The longevity biology research community has been the most active area of peptide-adjacent research over the past decade. The FOXO signaling axis, the mTOR pathway, the SIRT1/NAD⁺ system, and telomere biology represent precisely the molecular targets that longevity-focused research groups have been examining in the context of various biological interventions aimed at supporting cellular aging processes.

What this research has consistently underscored — but what popular longevity discourse often glosses over — is that the genetic context in which any such intervention operates varies substantially between individuals. A protocol designed around mTOR pathway modulation operates against a fundamentally different biological backdrop in someone with inherited high-baseline mTOR activity versus someone with a lower set point. A SIRT1-targeting approach encounters a different cellular environment depending on whether an individual carries variants that enhance or attenuate baseline SIRT1 activity and NAD⁺ sensitivity.

This is not a theoretical concern. It is the reason that longevity research groups are increasingly focused on genetic stratification — understanding which biological subgroups respond to which interventions — rather than pursuing one-size-fits-all anti-aging protocols that work well in some individuals and produce minimal measurable benefit in others.

Genetics is a guide, not a guarantee. Your longevity pathway genetic profile does not determine your lifespan. What it does is provide the biological context your healthcare provider needs to design an aging biology protocol grounded in your actual inherited cellular architecture — not the population average. Test before you invest in any longevity protocol. Your FOXO3 genotype, your TERT variant, your KLOTHO status, your mTOR signaling architecture — these are not abstractions. They are the molecular foundation of how your cells age.

What PlexusDx Analyzes in the Longevity & Aging Pathway

The Longevity & Aging pathway in the PlexusDx Precision Peptide Genetic Test includes 17 genetic insights — the second-largest pathway in the full panel, behind only Weight Management (33 insights), reflecting the depth and maturity of genetic research connecting inherited variation to cellular aging biology.

The 17 Longevity & Aging insights sit within a full panel that analyzes 48 unique genes and 57 unique SNPs, delivering 150 total genetic insights across all 14 pathways. All samples are processed on the Illumina Global Screening Array in CLIA-certified laboratories — the same institutional-grade platform used in major academic longevity research cohorts. Results are delivered through the Peptide Pathways Report in the PlexusDx Results Portal, where each genetic insight is presented with your personal genotype context and educational framing designed to support an informed conversation with your healthcare provider.

The other 13 pathways in the full panel — including Weight Management, Muscle Growth, Skin Health, Energy Metabolism, Immunity, Tissue Repair, Mood, Cognition, Inflammation, Reproductive Health, Sexual Health, Brain Health, and Sleep — provide the complete biological picture that surrounds your longevity results. Because aging biology does not operate in isolation from metabolic health, immune function, cognitive resilience, and tissue integrity, having all 14 pathways analyzed simultaneously is what transforms individual longevity data points into a coherent, integrated biological profile.

Who Should Know Their Longevity Genetic Profile

  • Anyone working with a longevity medicine physician, integrative health specialist, or functional medicine practitioner on a biological age management or healthspan optimization protocol
  • Biohackers and precision health practitioners building a genetics-first framework for their longevity strategy — so that every protocol decision is grounded in their actual cellular aging biology rather than population-level assumptions
  • Individuals with family histories of age-related cognitive decline, cardiovascular aging, or early biological aging who want to understand their inherited cellular resilience architecture
  • High-performance athletes and serious fitness practitioners tracking biological aging markers as part of a comprehensive performance and longevity strategy
  • Healthcare providers building genotype-informed longevity protocols for patients seeking precision approaches to biological age management

Already Have a PlexusDx Genetic Profile on File?

If you have previously completed a PlexusDx genetic test, your DNA data is already on file. The Peptide Pathways Report is available as a standalone add-on — delivering all 17 Longevity & Aging genetic insights alongside the complete 150-insight, 14-pathway panel, with no new sample required. Your FOXO3 status, TERT variant, KLOTHO genotype, mTOR signaling architecture, and SIRT1 pathway profile, unlocked from your existing genetic data.

Frequently Asked Questions About Longevity Genetics

Why is FOXO3 considered the most important longevity gene, and what does my genotype actually tell me?

FOXO3 rs2802292 has been replicated in more independent human longevity cohorts — across more ancestral populations and both sexes — than any other common genetic variant in the longevity literature. The longevity-associated G allele is thought to produce a more robust FOXO3 stress-resistance response, amplifying downstream DNA repair, oxidative stress detoxification, and cellular maintenance activity. Your genotype tells you where your inherited stress-resistance signaling sits relative to the population — useful context for any longevity protocol your healthcare provider designs. Genetics is a guide, not a guarantee.

Does the PlexusDx Precision Peptide Genetic Test tell me which longevity interventions are right for me?

No. The test analyzes how your genes influence peptide-related biological pathways, including 17 Longevity & Aging insights covering FOXO3, TERT, KLOTHO, SIRT1, and mTOR signaling. It does not recommend, prescribe, or determine which peptides, supplements, or therapeutic interventions to use. Your results provide the genetic baseline your healthcare provider needs to design a longevity protocol calibrated to your actual cellular aging architecture. Always consult a qualified healthcare provider before beginning any longevity or anti-aging protocol.

How many genetic insights are in the Longevity & Aging pathway, and what does the full panel cover?

The Longevity & Aging pathway includes 17 genetic insights — the second-largest of 14 peptide-related biological pathways in the Precision Peptide Genetic Test, behind Weight Management (33 insights). The full panel analyzes 48 unique genes and 57 unique SNPs, delivering 150 total genetic insights across weight management, longevity, muscle growth, skin health, energy metabolism, immunity, tissue repair, mood, cognition, inflammation, reproductive health, sexual health, brain health, and sleep. All samples are processed on the Illumina Global Screening Array in CLIA-certified laboratories.

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Ready to understand your longevity genetics — FOXO3, TERT, KLOTHO, SIRT1, and 13 more aging biology insights?

👉 Get the Precision Peptide Genetic Test — 14 pathways, 49 unique peptides analyzed, 150 genetic insights, processed on the Illumina Global Screening Array in a CLIA-certified laboratory.

👉 Already tested? Add the Peptide Pathways Report — no new sample required. Unlock your complete Longevity & Aging pathway results — all 17 genetic insights — from your existing PlexusDx genetic data.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.